Literature DB >> 7728216

Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria.

Z Nagy1, M M Esiri, K A Jobst, J H Morris, E M King, B McDonald, S Litchfield, A Smith, L Barnetson, A D Smith.   

Abstract

We have performed a quantitative analysis of the amyloid load (plaques), neuritic plaques and neurofibrillary tangles (NFT) in the frontal, temporal and parietal association cortices of autopsied brains from 49 prospectively evaluated patients with Alzheimer's disease (AD) diagnosed according to three sets of published pathological criteria. These patients had been assessed clinically with psychological testing of cognitive abilities within 6 months of death. Correlations were sought between severity of pathological change and cognitive status before death, duration of disease and age at death. Using Khachaturian and CERAD criteria highly positive correlations were obtained between the extent of cognitive deficit and the density of NFT in frontal and parietal lobes. The percentage area of cortex occupied by amyloid in the parietal lobe was correlated to the cognitive deficit only in the CERAD-diagnosed cases. The density of all amyloid plaques (AP) showed no correlation with the extent of cognitive deficit, but the densities of neuritic plaques did correlate with cognitive deficit. Both amyloid load and tangle densities were positively correlated with disease duration. All these correlations were reduced or absent in a subgroup of cases fulfilling the Tierney et al. A3 diagnostic criteria for AD. We found no pathological measure that correlated with the age of patients at death. Amyloid loads and NFT densities showed highly significant but selective positive correlations, the most striking being between temporal lobe NFT density and frontal and parietal lobe amyloid load and between temporal lobe NFT density and frontal and parietal lobe NFT densities. Correlations involving AP density as a measure of amyloid load were almost always less significant than those involving the percentage area of cortex occupied by amyloid, suggesting that the latter measures amyloid load more accurately. However, the highest correlations of NFT densities were with neuritic plaque densities. Overall this study highlights the relevance of neuritic changes (revealed by NFT and neuritic plaques) and the irrelevance of amyloid plaques to the dementia of AD.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7728216     DOI: 10.1159/000106918

Source DB:  PubMed          Journal:  Dementia        ISSN: 1013-7424


  66 in total

1.  S100beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease.

Authors:  W H Yu; P E Fraser
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

2.  Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

Authors:  M C Irizarry; F Soriano; M McNamara; K J Page; D Schenk; D Games; B T Hyman
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

3.  Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease.

Authors:  R B Knowles; C Wyart; S V Buldyrev; L Cruz; B Urbanc; M E Hasselmo; H E Stanley; B T Hyman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

4.  Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.

Authors:  T Gómez-Isla; J L Price; D W McKeel; J C Morris; J H Growdon; B T Hyman
Journal:  J Neurosci       Date:  1996-07-15       Impact factor: 6.167

Review 5.  Neurogenetics II: complex disorders.

Authors:  A F Wright
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

6.  Neuropathological associates of multiple cognitive functions in two community-based cohorts of older adults.

Authors:  N Maritza Dowling; Sarah Tomaszewski Farias; Bruce R Reed; Joshua A Sonnen; Milton E Strauss; Julie A Schneider; David A Bennett; Dan Mungas
Journal:  J Int Neuropsychol Soc       Date:  2011-07       Impact factor: 2.892

7.  Characterization of Japanese-American men with a single neocortical AD lesion type.

Authors:  Helen Petrovitch; G Webster Ross; Qimei He; Jane Uyehara-Lock; William Markesbery; Daron Davis; James Nelson; Kamal Masaki; Lenore Launer; Lon R White
Journal:  Neurobiol Aging       Date:  2007-05-17       Impact factor: 4.673

8.  Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease.

Authors:  Sylvia E Perez; Bin He; Muhammad Nadeem; Joanne Wuu; Stephen W Scheff; Eric E Abrahamson; Milos D Ikonomovic; Elliott J Mufson
Journal:  Biol Psychiatry       Date:  2014-01-11       Impact factor: 13.382

Review 9.  Alzheimer disease therapy--moving from amyloid-β to tau.

Authors:  Ezio Giacobini; Gabriel Gold
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

Review 10.  Genomic variants, genes, and pathways of Alzheimer's disease: An overview.

Authors:  Adam C Naj; Gerard D Schellenberg
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.